These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12240742)

  • 1. Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy.
    Richardson JL; Martin EM; Jimenez N; Danley K; Cohen M; Carson VL; Sinclair B; Racenstein JM; Reed RA; Levine AM
    J Int Neuropsychol Soc; 2002 Sep; 8(6):781-93. PubMed ID: 12240742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women.
    Richardson JL; Nowicki M; Danley K; Martin EM; Cohen MH; Gonzalez R; Vassileva J; Levine AM
    AIDS; 2005 Oct; 19(15):1659-67. PubMed ID: 16184036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men.
    Lake JE; Vo QT; Jacobson LP; Sacktor N; Miller EN; Post WS; Becker JT; Palella FJ; Ragin A; Martin E; Munro CA; Brown TT
    Antivir Ther; 2015; 20(2):235-44. PubMed ID: 25810377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.
    Boodram B; Plankey MW; Cox C; Tien PC; Cohen MH; Anastos K; Karim R; Hyman C; Hershow RC
    AIDS Patient Care STDS; 2009 Dec; 23(12):1009-16. PubMed ID: 19909168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
    Silverberg MJ; Gore ME; French AL; Gandhi M; Glesby MJ; Kovacs A; Wilson TE; Young MA; Gange SJ
    Clin Infect Dis; 2004 Sep; 39(5):717-24. PubMed ID: 15356788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.
    Wojna V; Robles L; Skolasky RL; Mayo R; Selnes O; de la Torre T; Maldonado E; Nath A; Meléndez LM; Lasalde-Dominicci J
    J Neurovirol; 2007 Dec; 13(6):561-8. PubMed ID: 18097887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.
    Cohen RA; Boland R; Paul R; Tashima KT; Schoenbaum EE; Celentano DD; Schuman P; Smith DK; Carpenter CC
    AIDS; 2001 Feb; 15(3):341-5. PubMed ID: 11273214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.
    Hessol NA; Kalinowski A; Benning L; Mullen J; Young M; Palella F; Anastos K; Detels R; Cohen MH
    Clin Infect Dis; 2007 Jan; 44(2):287-94. PubMed ID: 17173233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and neurocognitive performance in Portuguese patients infected with HIV.
    Bragança M; Palha A
    AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
    Cysique LA; Brew BJ
    J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS).
    Kuo WH; Wilson TE; Weber KM; Madhava V; Richardson J; Delapenha R; Des Jarlais D
    AIDS Patient Care STDS; 2004 Dec; 18(12):702-13. PubMed ID: 15659881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance.
    Rothlind JC; Greenfield TM; Bruce AV; Meyerhoff DJ; Flenniken DL; Lindgren JA; Weiner MW
    J Int Neuropsychol Soc; 2005 Jan; 11(1):70-83. PubMed ID: 15686610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS).
    Sacktor NC; Lyles RH; Skolasky RL; Anderson DE; McArthur JC; McFarlane G; Selnes OA; Becker JT; Cohen B; Wesch J; Miller EN
    Neurology; 1999 May; 52(8):1640-7. PubMed ID: 10331692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.
    Thaler NS; Sayegh P; Kim MS; Castellon SA; Hinkin CH
    Arch Clin Neuropsychol; 2015 Mar; 30(2):114-21. PubMed ID: 25589442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART.
    Terzian AS; Holman S; Nathwani N; Robison E; Weber K; Young M; Greenblatt RM; Gange SJ;
    J Womens Health (Larchmt); 2009 Dec; 18(12):1965-74. PubMed ID: 20044858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group.
    Hessol NA; Anastos K; Levine AM; Ameli N; Cohen M; Young M; Augenbraun M; Miotti P; Gange SJ
    AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1105-11. PubMed ID: 10954885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.
    Rabkin JG; Ferrando SJ; van Gorp W; Rieppi R; McElhiney M; Sewell M
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):451-7. PubMed ID: 11083161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
    Heaton RK; Clifford DB; Franklin DR; Woods SP; Ake C; Vaida F; Ellis RJ; Letendre SL; Marcotte TD; Atkinson JH; Rivera-Mindt M; Vigil OR; Taylor MJ; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Abramson I; Gamst A; Fennema-Notestine C; Jernigan TL; Wong J; Grant I;
    Neurology; 2010 Dec; 75(23):2087-96. PubMed ID: 21135382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.